CN
Centessa Pharmaceuticals plc
CNTA · NASDAQ
$40.50 +1.02% (+$0.41)
Market Cap $6.27B
P/E Ratio -
Div. Yield -
ROE 55.42%
Bulios Fair Price
$25.5
37.0% downside
Trenutna cena
$40.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CNTA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 12.86x
P/S 417.78x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 324.06%
FCF growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,459.95%
Gross margin 100.00%
FCF margin 1,403.96%
Quality
0 /100
Poor ROA 32.82%
ROIC 36.74%
Asset turnover 0.02x
Debt
80 /100
Low Int. coverage -20.33x
Debt/Equity 0.02x
Net debt/EBITDA 0.28x
Stability
27 /100
Unstable Profitable years 0
Beta 1.12x
EPS volatility 3,115.19%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CNTA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mario Alberto Accardi
Employees
129
Headquarters
Altrincham